Shlevin Harold H. insider trades
Shlevin Harold H. has filed 9 Form 4s with the SEC that we hold, all for Galectin Therapeutics INC (GALT), as Director. Across all of them we count 1 purchase worth $7.5K and 14 sales worth $1.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 14 sales ($1.6M). The largest single trade was a sale of 35,000 shares of Galectin Therapeutics INC worth $210.7K, dated 2025-12-08. The first filing on our record is dated 2022-01-25 and the latest 2026-06-30.
Galectin Therapeutics INC (GALT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-12-30 | P, purchase reported on Form 4 | 6,500 | $7.5K | 2024-12-31 |
| 2025-12-08 | S, sale reported on Form 4 | 20,000 | $119.2K | 2025-12-10 |
| 2025-12-08 | S, sale reported on Form 4 | 35,000 | $208.2K | 2025-12-10 |
| 2025-12-08 | S, sale reported on Form 4 | 4,000 | $24.0K | 2025-12-10 |
| 2025-12-08 | S, sale reported on Form 4 | 25,000 | $148.8K | 2025-12-10 |
| 2025-12-08 | S, sale reported on Form 4 | 35,000 | $210.7K | 2025-12-10 |
| 2025-12-08 | S, sale reported on Form 4 | 20,000 | $120.0K | 2025-12-10 |
| 2025-12-08 | S, sale reported on Form 4 | 20,000 | $119.2K | 2025-12-10 |
| 2025-12-09 | S, sale reported on Form 4 | 16,790 | $105.3K | 2025-12-10 |
| 2025-12-12 | S, sale reported on Form 4 | 19,793 | $124.1K | 2025-12-16 |
| 2025-12-15 | S, sale reported on Form 4 | 8,417 | $53.0K | 2025-12-16 |
| 2025-12-17 | S, sale reported on Form 4 | 4,706 | $33.1K | 2025-12-19 |
| 2025-12-17 | S, sale reported on Form 4 | 19,793 | $139.3K | 2025-12-19 |
| 2026-06-26 | S, sale reported on Form 4 | 7,732 | $38.7K | 2026-06-30 |
| 2026-06-29 | S, sale reported on Form 4 | 22,268 | $112.2K | 2026-06-30 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1557082) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms